Self-administered Subcutaneous Daratumumab in Patients With Multiple Myeloma
Clinical trial NCT07191379 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07191379
- Sponsor
- Odense University Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2027-06-29
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.